PartnersPRN is proud to present Managing Patients with Hemophilia with Inhibitors: Challenging Cases provided by the University of Nebraska Medical Center College of Nursing Continuing Nursing Education and the National Hemophilia Foundation.
This activity was held in conjunction with the National Hemophilia Foundation’s 65th Annual Meeting held October 2013. Three case studies involving patients with hemophilia with inhibitors are presented.
Target Audience
This activity is intended for nurses interested in the treatment and care of patients with hemophilia with inhibitors. Healthcare professionals treating such patients must stay abreast of recent clinical research and best practices among their peers in order to provide their patients with appropriate evidenced-based treatment.
Purpose
The purpose of this activity is to enable the learner to develop deep understanding of the etiology, treatment, and management of complex cases of hemophilia involving inhibitors that will enhance the nurses’ ability to advocate for, manage, and educate patients.
Learning Objectives
Upon completion of this learning activity, participants should be better able to:
Program Faculty
Sue Purdie, BSN, RN: Children’s Hospitals & Clinics of Minnesota
Glen Roy, RN: Maine Hemophilia & Thrombosis Center
Michelle Witkop, DNP, FNP-BC: Northern Regional Bleeding Disorders Center, Munson Medical Center
Moderator: Leonard A. Valentino, MD: Rush University Medical Center
Accreditation Statement
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is provided for 1.0 contact hours under ANCC criteria.
Here’s how to participate:
HTC staff should login under the “Education for HTCs-By HTCs” section of the home page. All others can find this activity by signing in under “Education for All Healthcare Providers”. This activity is located in the “Inhibitors” category.
Thank you!
This activity is supported by an educational grant from Novo Nordisk Inc.
The PartnersPRN has launched a new complimentary continuing education activity titled Cardiovascular Disease in an Adult with Hemophilia.
Program Overview
Thanks to the availability of clotting factor concentrates and the multidisciplinary care provided at hemophilia treatment centers (HTCs), the life expectancy of persons with hemophilia now approaches that of the general male population. But this means more individuals with hemophilia are at risk for, or are experiencing, age-related diseases, including cardiovascular disease.
Using a clinical scenario that is becoming more common at HTCs, this interactive online learning activity reviews the prevalence of cardiovascular disease among individuals with hemophilia and summarizes recommendations from HTCs across the world that are experienced in managing such patients.
Module Authors
Accreditation Statements and Credit Designations
Physicians
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 1.0 contact hours under ANCC criteria.
Participate in this Complimentary CE Activity Today!
HTC staff should login under the "Education for HTCs-By HTCs" section of the home page. All others can find this activity by signing in under "Education for All Healthcare Providers". This activity is located in the "Bleeding Disorders Interactive Primer" category.
Introducing a new PartnersPRN online learning course, Pharmacy/340B in the HTC!
This learning module describes previous and current pharmaceutical treatments and adjuvant therapies and products currently under development for patients with bleeding disorders. It also provides information about the role of the 340B Pharmacy Program in assisting patients to access these products.
This learning module is available exclusively to HTC staff! Login under the "Education For HTCs-By HTCs" section click on the black box "Click Here for Online Educational Modules". This activity is located in "The Basics" category.
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 1.25 contact hours under ANCC criteria.
0.2 contact hours are related to pharmacotherapeutic content.
Announcing the NEW and improved PartnersPRN website! For technical support, contact us at adminpartnersprn@partnersprn.org.